Neal Walker

2019

In 2019, Neal Walker earned a total compensation of $3.2M as President and Chief Executive Officer at Aclaris Therapeutics, a 28% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$203,940
Salary$499,875
Stock Awards$2,434,518
Other$11,688
Total$3,150,021

Walker received $2.4M in stock awards, accounting for 77% of the total pay in 2019.

Walker also received $203.9K in non-equity incentive plan, $499.9K in salary and $11.7K in other compensation.

Rankings

In 2019, Neal Walker's compensation ranked 3,885th out of 13,971 executives tracked by ExecPay. In other words, Walker earned more than 72.2% of executives.

ClassificationRankingPercentile
All
3,885
out of 13,971
72nd
Division
Manufacturing
1,401
out of 5,701
75th
Major group
Chemicals And Allied Products
492
out of 2,200
78th
Industry group
Drugs
415
out of 1,886
78th
Industry
Pharmaceutical Preparations
316
out of 1,398
77th
Source: SEC filing on April 23, 2020.

Walker's colleagues

We found three more compensation records of executives who worked with Neal Walker at Aclaris Therapeutics in 2019.

2019

David ChB

Aclaris Therapeutics

Chief Medical Officer

2019

David Gordon

Aclaris Therapeutics

Chief Medical Officer

2019

Frank Ruffo

Aclaris Therapeutics

Chief Financial Officer

News

You may also like